Dr. Michael Jandke has a strong background in regulatory affairs, particularly in ATMP and generics. With experience at companies like Miltenyi Biomedicine, Codon AG, Cytonet GmbH & Co. KG, and HELM AG, Dr. Jandke has a wide range of experience in managing regulatory processes for pharmaceuticals. Dr. Michael's academic background includes a PhD in Molecular Medicine and Pharmacy from Humboldt-Universität zu Berlin.
April, 2019 - present